Search
for
Sort by
Research 151–180 of 1000+
- Niosomes as a propitious carrier for topical drug delivery
- Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease
- A preliminary study of finasteride in Tourette syndrome
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Genome-wide meta-analysis implicates mediators of hair follicle development and morphogenesis in risk for severe acne
- Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up
- Anabolic-androgenic steroids and cardiovascular risk
- Psychocutaneous disease
- Evaluation of affective temperament and anxiety–depression levels of patients with polycystic ovary syndrome
- Polycystic Ovarian Syndrome: Long-Term Health Consequences
- Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy
- Adverse health effects of androgen use
- Guidelines for the Use of Acitretin in Psoriasis
- Topical Minoxidil
- Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology
- Cross-sex hormone therapy for gender dysphoria
- Secondary cicatricial and other permanent alopecias
- Considerations in genetic counseling of transgender patients: Cultural competencies and altered disease risk profiles
- Pathological findings in a case of stiff person syndrome with anti‐GAD antibodies
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- Niosomes as Carrier in Dermal Drug Delivery
- Oral vitamin A as an adjunct treatment for canine sebaceous adenitis
- Potential Medical Uses of Cannabigerol: A Brief Overview
- Evolving approaches to profiling the microbiome in skin disease
- Squarticles as the nanoantidotes to sequester the overdosed antidepressant for detoxification
- Feasibility of implementing current best clinical practice for people who are using anabolic androgenic steroids within a Swiss primary care practice: a quality assurance study
- Shedding light on therapeutics in alopecia and their relevance to COVID-19
- Drug safety evaluation of exemestane
- Recent therapeutic developments for acne
- Update on psychodermatological disorders